Titlebook: Biology and Treatment of Leukemia and Bone Marrow Neoplasms; Vinod Pullarkat,Guido Marcucci Book 2021 Springer Nature Switzerland AG 2021

cucumber

書目名稱Biology and Treatment of Leukemia and Bone Marrow Neoplasms影響因子(影響力)




書目名稱Biology and Treatment of Leukemia and Bone Marrow Neoplasms影響因子(影響力)學科排名




書目名稱Biology and Treatment of Leukemia and Bone Marrow Neoplasms網(wǎng)絡公開度




書目名稱Biology and Treatment of Leukemia and Bone Marrow Neoplasms網(wǎng)絡公開度學科排名




書目名稱Biology and Treatment of Leukemia and Bone Marrow Neoplasms被引頻次




書目名稱Biology and Treatment of Leukemia and Bone Marrow Neoplasms被引頻次學科排名




書目名稱Biology and Treatment of Leukemia and Bone Marrow Neoplasms年度引用




書目名稱Biology and Treatment of Leukemia and Bone Marrow Neoplasms年度引用學科排名




書目名稱Biology and Treatment of Leukemia and Bone Marrow Neoplasms讀者反饋




書目名稱Biology and Treatment of Leukemia and Bone Marrow Neoplasms讀者反饋學科排名

猛擊

紅潤

enchant

https://doi.org/10.1007/978-3-658-17357-9-AHN. The clinical presentation of SM can range from indolent to advanced depending on extent of mast cell burden and genetic profile. In the case of indolent SM, the goal of treatment is to control mediator release-related effects?as well as to reduce mast cell burden. In the case of SM-AHN, therap

加花粗鄙人

搖曳的微光

Systemic Mastocytosis: Advances in Diagnosis and Current Management,-AHN. The clinical presentation of SM can range from indolent to advanced depending on extent of mast cell burden and genetic profile. In the case of indolent SM, the goal of treatment is to control mediator release-related effects?as well as to reduce mast cell burden. In the case of SM-AHN, therap

Fillet,Filet

0927-3042 ment of leukemias and bone marrow malignancies. The book is of special interest for hematologists, oncologists, and cancer researchers; it is also of value for hematology trainees and medical students..978-3-030-78313-6978-3-030-78311-2Series ISSN 0927-3042 Series E-ISSN 2509-8497

失敗主義者

0927-3042 targets for leukemia therapy.Provides comprehensive coverage.This book provides a concise update on current understanding of the biology of acute and chronic leukemias and other bone marrow neoplasms, including myelodysplastic and myeloproliferative disorders, and explores new and emerging treatment

語源學

https://doi.org/10.1007/978-3-662-53687-2ologic neoplasms have moved from traditional histology and immunophenotyping to integration of cytogenetic and genomic alterations. Using illustrative cases, this chapter provides an overview of the utility of using genomic data for prognostication as well as treatment decision-making for patients with bone marrow neoplasms.

Insatiable